These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8786728)

  • 1. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity.
    Young AA; Wang MW; Gedulin B; Rink TJ; Pittner R; Beaumont K
    Metabolism; 1995 Dec; 44(12):1581-9. PubMed ID: 8786728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity amylin binding sites in rat brain.
    Beaumont K; Kenney MA; Young AA; Rink TJ
    Mol Pharmacol; 1993 Sep; 44(3):493-7. PubMed ID: 8396712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
    Young AA; Rink TJ; Wang MW
    Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.
    Pittner RA; Wolfe-Lopez D; Young AA; Beaumont K
    Br J Pharmacol; 1996 Mar; 117(5):847-52. PubMed ID: 8851500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms.
    Castle AL; Kuo CH; Ivy JL
    Am J Physiol; 1998 Jan; 274(1):E6-12. PubMed ID: 9458741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
    Haynes JM; Hodgson WC; Cooper ME
    Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats.
    Young AA; Cooper GJ; Carlo P; Rink TJ; Wang MW
    Am J Physiol; 1993 Jun; 264(6 Pt 1):E943-50. PubMed ID: 8333519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response for glucagonostatic effect of amylin in rats.
    Gedulin BR; Rink TJ; Young AA
    Metabolism; 1997 Jan; 46(1):67-70. PubMed ID: 9005972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of biologically active tritiated amylin and salmon calcitonin analogues.
    Heller M; Loomes KM; Cooper GJ
    Anal Biochem; 2000 Oct; 285(1):100-4. PubMed ID: 10998268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved.
    Beaumont K; Pittner RA; Moore CX; Wolfe-Lopez D; Prickett KS; Young AA; Rink TJ
    Br J Pharmacol; 1995 Jul; 115(5):713-5. PubMed ID: 8548167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats.
    Vine W; Beaumont K; Gedulin B; Pittner R; Moore CX; Rink TJ; Young AA
    Eur J Pharmacol; 1996 Oct; 314(1-2):115-21. PubMed ID: 8957226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: study in the perfused pancreas of the rat.
    Silvestre RA; Salas M; Rodríguez-Gallardo J; García-Hermida O; Fontela T; Marco J
    Br J Pharmacol; 1996 Jan; 117(2):347-50. PubMed ID: 8789389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular physiology of amylin.
    Pittner RA; Albrandt K; Beaumont K; Gaeta LS; Koda JE; Moore CX; Rittenhouse J; Rink TJ
    J Cell Biochem; 1994; 55 Suppl():19-28. PubMed ID: 7929615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin.
    Wookey PJ; Tikellis C; Du HC; Qin HF; Sexton PM; Cooper ME
    Am J Physiol; 1996 Feb; 270(2 Pt 2):F289-94. PubMed ID: 8779889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on plasma glucose and lactate.
    Young A
    Adv Pharmacol; 2005; 52():193-208. PubMed ID: 16492547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmon calcitonin binding and stimulation of cyclic AMP generation in rat skeletal muscle.
    Kenney MA; Moore CX; Pittner R; Beaumont K
    Biochem Biophys Res Commun; 1993 Nov; 197(1):8-14. PubMed ID: 8250950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin-induced suppression of ANP secretion through receptors for CGRP1 and salmon calcitonin.
    Piao FL; Cao C; Han JH; Kim SZ; Cho KW; Kim SH
    Regul Pept; 2004 Mar; 117(3):159-66. PubMed ID: 14749035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amylin-mediated inhibition of insulin-stimulated glucose transport in skeletal muscle.
    Castle AL; Kuo CH; Han DH; Ivy JL
    Am J Physiol; 1998 Sep; 275(3):E531-6. PubMed ID: 9725822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin.
    Young AA; Gedulin B; Gaeta LS; Prickett KS; Beaumont K; Larson E; Rink TJ
    FEBS Lett; 1994 May; 343(3):237-41. PubMed ID: 8174707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).
    Lutz TA; Tschudy S; Rushing PA; Scharrer E
    Peptides; 2000 Feb; 21(2):233-8. PubMed ID: 10764950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.